Plexus CEO sells 1,500 shares in pre-set plan

Plexus Corp President & CEO Todd P. Kelsey reported two open-market sales totaling 1,500 shares of Plexus common stock on July 15, 2026.

Rhea-AI Filing Summary

Plexus Corp President & CEO Todd P. Kelsey reported two open-market sales totaling 1,500 shares of Plexus common stock on July 15, 2026. The sales covered 1,000 shares at a weighted average price of $261.0701 and 500 shares at $260.5100 per share, executed pursuant to a Rule 10b5-1 plan adopted on November 20, 2025. One transaction was completed in multiple trades between $261.00 and $261.68 per share, with the disclosed price representing the weighted average.

Insider Trade Summary 10b5-1

Net Seller: 1,500 shares

Net Sell 2 txns

Insider Kelsey Todd P.

Role President & CEO

Sold 1,500 shs ($391K)

Type	Security	Shares	Price	Value
Sale	Common Stock, $.01 par value F1	500	$260.51	$130K
Sale	Common Stock, $.01 par value F1, F2	1,000	$261.0701	$261K

Holdings After Transaction: Common Stock, $.01 par value — 67,388 shares (Direct)

Footnotes (2)

1. F1. Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.
2. F2. This transaction was executed in multiple trades at prices ranging from $261.00 to $261.68 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Total shares sold: 1,500 shares First sale size and price: 1,000 shares at $261.0701 Second sale size and price: 500 shares at $260.5100 +3 more

6 metrics

Total shares sold 1,500 shares Non-derivative open-market sales reported for July 15, 2026

First sale size and price 1,000 shares at $261.0701 Weighted average sale price for one transaction of common stock

Second sale size and price 500 shares at $260.5100 Price per share for second open-market sale of common stock

Intraday price range $261.00 to $261.68 Range of prices for trades underlying the 1,000-share sale

Rule 10b5-1 plan adoption date November 20, 2025 Date Kelsey’s trading plan governing these sales was adopted

Net shares sold 1,500 shares Net buy/sell shares in transaction summary (net-sell direction)

Key Terms

Rule 10b5-1 plan, open-market sale, weighted average sale price

3 terms

Rule 10b5-1 plan regulatory

"Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025."

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

open-market sale financial

"transaction_action: open-market sale for both non-derivative transactions."

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

weighted average sale price financial

"The reported price reflects the weighted average sale price for the transaction."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did PLXS President & CEO Todd P. Kelsey report?

Todd P. Kelsey reported selling 1,500 shares of Plexus Corp common stock. The Form 4 shows two open-market transactions on July 15, 2026, reflecting planned sales under a previously adopted Rule 10b5-1 trading plan.

At what prices were Todd P. Kelsey’s PLXS shares sold?

Kelsey sold 1,000 shares at $261.0701 and 500 shares at $260.5100 per share. One 1,000-share transaction was executed in multiple lots between $261.00 and $261.68, with the reported price representing the weighted average sale price.

How many PLXS shares did Todd P. Kelsey sell in total on July 15, 2026?

The Form 4 reports that Kelsey sold 1,500 PLXS shares in total. This consisted of two separate non-derivative open-market sales of common stock, one for 1,000 shares and another for 500 shares, both executed on July 15, 2026.

Were Todd P. Kelsey’s PLXS share sales made under a Rule 10b5-1 plan?

Yes. A footnote states the shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025. Such pre-arranged plans schedule trades in advance and can reduce the significance of trade timing as an information signal.

What types of securities are involved in Todd P. Kelsey’s PLXS Form 4 filing?

The filing reports transactions only in common stock with a par value of $.01 per share. The transaction summary shows two non-derivative open-market sales and no option exercises, gifts, tax-withholding dispositions, or other derivative transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/16/2026 - 04:58 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kelsey Todd P.

(Last) (First) (Middle)

ONE PLEXUS WAY

(Street)

NEENAH WISCONSIN 54956

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PLEXUS CORP [ PLXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.01 par value	07/15/2026		S(1)		500	D	$260.51	68,388	D
Common Stock, $.01 par value	07/15/2026		S(1)		1,000	D	$261.0701(2)	67,388	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.

2. This transaction was executed in multiple trades at prices ranging from $261.00 to $261.68 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

	/s/ Todd P. Kelsey, by Kate A. Gitter, Attorney-in-Fact	07/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)